Erlocip Erlotinib 150mg Tablet
| Active Ingredient (Generic Name) | Erlotinib |
|---|---|
| Indication | Erlotinib150mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. |
| Manufacturer | Cipla |
| Packaging | 30 tablets in 1 bottle |
| Strength | 150mg |
| Delivery Time | 8 Days |
Product Name: Erlotinib 150mg Tablet
Brand Name: Erlotinib
Composition: Erlotinib (150 mg)
Form: Tablet
Dosage Form: Oral
Dose/Strength: 150 mg
Packaging Size: 30 Tablets per Strip
Packaging Type: Strip
Manufacturer: Cipla
Prescription Status: Prescription Only
Form of Medicine: Allopathic
Usage/Application: As directed by a physician
Description:
Erlotinib 150mg Tablet is an oral cancer medication used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of a specific protein (epidermal growth factor receptor, EGFR) that promotes cancer cell growth.
Erlotinib is most effective in patients with EGFR mutation-positive tumors and is often prescribed as a first-line or maintenance therapy in advanced stages of cancer.
Indications:
-
Non-small cell lung cancer (NSCLC)
-
Locally advanced or metastatic pancreatic cancer (in combination with gemcitabine)
Key Features:
-
Each tablet contains 150 mg of Erlotinib
-
Manufactured by Cipla, a leading global pharmaceutical company
-
Convenient 30-tablet strip packaging
-
Used as part of targeted cancer therapy, offering specificity in treatment
-
$69.00 - $99.00 -
$79.00 - $181.00
-
$59.00 - $95.00
-
$45.00 - $121.00
-
$95.00 - $200.00
-
$395.00 - $990.00
Reviews & Ratings
Product Name: Erlotinib 150mg Tablet
Brand Name: Erlotinib
Composition: Erlotinib (150 mg)
Form: Tablet
Dosage Form: Oral
Dose/Strength: 150 mg
Packaging Size: 30 Tablets per Strip
Packaging Type: Strip
Manufacturer: Cipla
Prescription Status: Prescription Only
Form of Medicine: Allopathic
Usage/Application: As directed by a physician
Description:
Erlotinib 150mg Tablet is an oral cancer medication used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of a specific protein (epidermal growth factor receptor, EGFR) that promotes cancer cell growth.
Erlotinib is most effective in patients with EGFR mutation-positive tumors and is often prescribed as a first-line or maintenance therapy in advanced stages of cancer.
Indications:
-
Non-small cell lung cancer (NSCLC)
-
Locally advanced or metastatic pancreatic cancer (in combination with gemcitabine)
Key Features:
-
Each tablet contains 150 mg of Erlotinib
-
Manufactured by Cipla, a leading global pharmaceutical company
-
Convenient 30-tablet strip packaging
-
Used as part of targeted cancer therapy, offering specificity in treatment
Frequently Brought Products
-
$69.00 - $99.00
-
$79.00 - $181.00
-
$59.00 - $95.00
-
$45.00 - $121.00
-
$95.00 - $200.00
-
$395.00 - $990.00
